Super-pharm sales leap to NIS 2.65b. in 2006

Super-pharm posted its largest sales gain in seven years in 2006, generating revenues of NIS 2.65 billion, a six percent increase over 2005 levels.

By SHARON WROBEL
December 19, 2006 07:45

Super-pharm posted its largest sales gain in seven years in 2006, generating revenues of NIS 2.65 billion, a six percent increase over 2005 levels. "Despite the war in the North and the security situation this year, we achieved record sales this year and we expect to reach a target of NIS 2.9b. in sales in 2007," said Lior Reitblatt, President & CEO of Super-pharm. In 2006, the chain opened nine new branches, of which six were in the periphery and the Arab sector. Next year, Super-pharm plans to open 15 new branches extending its presence in these areas. Over the next three years, Super-pharm plans to focus on extending its activity in Poland as well as in China, where the chain recently purchased the Ensure pharmacy chain. In Poland, the company anticipates expanding its presence from the current 14 branches, which generated $40 million in revenues this year, to 50 branches by 2010.


Related Content

The Teva Pharmaceutical Industries
April 30, 2015
Teva doubles down on Mylan, despite rejection

By GLOBES, NIV ELIS

Israel Weather
  • 15 - 22
    Beer Sheva
    17 - 21
    Tel Aviv - Yafo
  • 14 - 20
    Jerusalem
    17 - 23
    Haifa
  • 19 - 28
    Elat
    17 - 30
    Tiberias